Levels of DAS28 have halved after the first three months of biological treatment (Fig. 1), (p < 0.001, F = 134.9), while concentration of CRP in plasma of RA patients during the same time decreased by 43%. The gene discussed is CRP; the disease is rheumatoid arthritis.